StockData
Anbio Biotechnology logo

Anbio Biotechnology (NNNN) stock

NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 11/30
$3.60−0.05 (-1.37%)

Close on Nov 18, 2026Market cap $518.01MP/E 24.5Yield –

Anbio Biotechnology net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was $6.40M, up 169.9% from the year before.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.40M+169.9%
FY2024Dec 31, 2024$2.37M+5.3%
FY2023Dec 31, 2023$2.25M-77.5%
FY2022Dec 31, 2022$10.01M–

More Anbio Biotechnology figures

See a number that looks wrong?